PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16092668-0 2005 Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients. Cisplatin 82-91 CD24 molecule Homo sapiens 54-58 34123574-7 2021 Gemcitabine or cisplatin-resistant cell lines show an increased proportion of CD44+/CD24+/EpCAM+ cancer stem like cells as well as an increased number of ABC transporter ABCG2 positive cells compared to the parental cell lines. Cisplatin 15-24 CD24 molecule Homo sapiens 84-88 34076552-5 2021 RESULTS: CD44 + CD24+ cells showed potential to form spheres, tumorigenicity, stemness genes and higher resistance to cisplatin, X-ray. Cisplatin 118-127 CD24 molecule Homo sapiens 16-20 34293822-11 2022 Finally, blocking CD24 by a monoclonal antibody enhanced sensitivity towards cisplatin in EC cells, including cisplatin-resistant subclones, highlighting CD24 as a putative target in combination with cisplatin. Cisplatin 77-86 CD24 molecule Homo sapiens 18-22 34293822-11 2022 Finally, blocking CD24 by a monoclonal antibody enhanced sensitivity towards cisplatin in EC cells, including cisplatin-resistant subclones, highlighting CD24 as a putative target in combination with cisplatin. Cisplatin 77-86 CD24 molecule Homo sapiens 154-158 34293822-11 2022 Finally, blocking CD24 by a monoclonal antibody enhanced sensitivity towards cisplatin in EC cells, including cisplatin-resistant subclones, highlighting CD24 as a putative target in combination with cisplatin. Cisplatin 110-119 CD24 molecule Homo sapiens 18-22 34293822-11 2022 Finally, blocking CD24 by a monoclonal antibody enhanced sensitivity towards cisplatin in EC cells, including cisplatin-resistant subclones, highlighting CD24 as a putative target in combination with cisplatin. Cisplatin 200-209 CD24 molecule Homo sapiens 18-22 33919109-0 2021 Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44+CD24- Sorted MDA-MB-231 Cells by Cisplatin. Cisplatin 131-140 CD24 molecule Homo sapiens 98-102 31904742-6 2020 Remarkably, MCF-7 CD24 cells were found to show high expression of ALDH1 protein which may have resulted in these cells exhibiting higher resistance against doxorubicin and cisplatin when compared with that of the parental cells. Cisplatin 173-182 CD24 molecule Homo sapiens 18-22 32194682-0 2020 Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer. Cisplatin 88-97 CD24 molecule Homo sapiens 110-114 32194682-1 2020 CD24, which is upregulated in several human malignancies, is related to Epithelial-mesenchymal-transition (EMT) and has characteristics of cancer stem-like cells, especially in cisplatin-resistant ovarian carcinoma cells. Cisplatin 177-186 CD24 molecule Homo sapiens 0-4 28179302-5 2017 Conversely, CD24 inhibition did not affect chemosensitivity to CDDP, while STAT1 inhibition reduced chemosensitivity to CDDP in CD24 siRNA-transfected cells. Cisplatin 120-124 CD24 molecule Homo sapiens 128-132 28440503-7 2017 CD24 induces the EMT phenomenon, which is involved in cell invasion, the highly proliferative phenotype, colony formation and which is associated with cisplatin resistance and the properties of CSCs, via the activation of PI3K/Akt, NF-kappaB and ERK in Caov-3 cisplatin-resistant cell lines. Cisplatin 151-160 CD24 molecule Homo sapiens 0-4 28440503-7 2017 CD24 induces the EMT phenomenon, which is involved in cell invasion, the highly proliferative phenotype, colony formation and which is associated with cisplatin resistance and the properties of CSCs, via the activation of PI3K/Akt, NF-kappaB and ERK in Caov-3 cisplatin-resistant cell lines. Cisplatin 260-269 CD24 molecule Homo sapiens 0-4 27924308-6 2016 Importantly, CD24+ side population (SP) CSLCs that are resistant to cisplatin are sensitive to Pt-NA, demonstrating the immense potential of Pt-NA for treating chemoresistant HCC. Cisplatin 68-77 CD24 molecule Homo sapiens 13-17 27276062-0 2016 CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma. Cisplatin 77-86 CD24 molecule Homo sapiens 0-4 27276062-5 2016 In this regard, CD24 expression level appears to be a significant molecular phenotype of cisplatin-resistant residual cells in laryngeal carcinoma lines. Cisplatin 89-98 CD24 molecule Homo sapiens 16-20 27276062-6 2016 CD24 expression level directly affects cisplatin sensitivity and affects the expression of critical apoptotic, stem and drug resistance genes. Cisplatin 39-48 CD24 molecule Homo sapiens 0-4 24612587-11 2014 In addition, the CD24+/CD44+ cells were more chemo-resistant to gemcitabine and cisplatin compared to CD24-/CD44+ cells. Cisplatin 80-89 CD24 molecule Homo sapiens 17-21 21726833-4 2011 With this model, we found CD24 to be upregulated in residual chemoresistant tumors when compared with bulk tumor upon cisplatin treatment. Cisplatin 118-127 CD24 molecule Homo sapiens 26-30 27276062-7 2016 A relatively small retrospective patient tumor analysis suggests that CD24 high tumors go on to show an unfavorable response to cisplatin treatment. Cisplatin 128-137 CD24 molecule Homo sapiens 70-74 25736055-9 2015 The CD24(+)/44(+) population was increased in GR and parent BTC cells treated with GEM or CDDP and highly expressed BRCA/FA genes. Cisplatin 90-94 CD24 molecule Homo sapiens 4-8 22995296-4 2012 The isolated CD24(+) CAOV3 and TOV21G cells were more resistant to cisplatin and doxorubicin anti-cancer drugs. Cisplatin 67-76 CD24 molecule Homo sapiens 13-17